These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17581372)

  • 21. Hydrogen Sulfide, a Potential Cardioprotective Gas Activating a Life Span Regulator.
    Ueda K; Fukuma N; Takimoto E
    Int Heart J; 2016 Jul; 57(4):393-4. PubMed ID: 27396562
    [No Abstract]   [Full Text] [Related]  

  • 22. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy.
    Miura T; Miki T
    Basic Res Cardiol; 2008 Nov; 103(6):501-13. PubMed ID: 18716709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo.
    Adameová A; Ravingerová T; Svec P; Faberová V; Kuzelová M
    Eur J Pharmacol; 2007 Dec; 576(1-3):114-21. PubMed ID: 17764671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac protection takes off.
    Piper HM; Garcia-Dorado D
    Cardiovasc Res; 2009 Jul; 83(2):163-4. PubMed ID: 19509028
    [No Abstract]   [Full Text] [Related]  

  • 25. Invited commentary.
    Thistlethwaite PA
    Ann Thorac Surg; 2013 Mar; 95(3):1033-4. PubMed ID: 23438530
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug discovery possibilities from visfatin cardioprotection?
    Hausenloy DJ
    Curr Opin Pharmacol; 2009 Apr; 9(2):202-7. PubMed ID: 19081303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning necrosis into apoptosis: the exacting task that can enhance survival.
    Chen-Scarabelli C; Scarabelli TM
    Am Heart J; 2004 Aug; 148(2):196-9. PubMed ID: 15308988
    [No Abstract]   [Full Text] [Related]  

  • 29. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan.
    Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P
    Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind, single centre, sub-chronic reperfusion trial evaluating FX06 following haemorrhagic shock in pigs.
    Roesner JP; Petzelbauer P; Koch A; Tran N; Iber T; Mutz C; Vollmar B; Nöldge-Schomburg GE; Zacharowski K
    Resuscitation; 2009 Feb; 80(2):264-71. PubMed ID: 19058891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.
    Takahama H; Minamino T; Asanuma H; Fujita M; Asai T; Wakeno M; Sasaki H; Kikuchi H; Hashimoto K; Oku N; Asakura M; Kim J; Takashima S; Komamura K; Sugimachi M; Mochizuki N; Kitakaze M
    J Am Coll Cardiol; 2009 Feb; 53(8):709-17. PubMed ID: 19232905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.
    Kloner RA; Nesto RW
    Circulation; 2008 May; 117(19):2523-33. PubMed ID: 18474824
    [No Abstract]   [Full Text] [Related]  

  • 33. BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.
    Krieg T; Liu Y; Rütz T; Methner C; Yang XM; Dost T; Felix SB; Stasch JP; Cohen MV; Downey JM
    Eur Heart J; 2009 Jul; 30(13):1607-13. PubMed ID: 19406872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Na+ currents in cardioprotection: better to be late.
    Le Grand B; Pignier C; Létienne R; Colpaert F; Cuisiat F; Rolland F; Mas A; Borras M; Vacher B
    J Med Chem; 2009 Jul; 52(14):4149-60. PubMed ID: 19514733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury.
    Hayashida K; Sano M; Ohsawa I; Shinmura K; Tamaki K; Kimura K; Endo J; Katayama T; Kawamura A; Kohsaka S; Makino S; Ohta S; Ogawa S; Fukuda K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):30-5. PubMed ID: 18541148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effect of ApolipoproteinA-I on myocardial ischemia-reperfusion injury in rats.
    Gu SS; Shi N; Wu MP
    Life Sci; 2007 Aug; 81(9):702-9. PubMed ID: 17698150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of TA-064, dopamine and isoproterenol on the acutely ischemic myocardium].
    Tokutake E; Watanabe I; Saito T; Hibiya K; Takahasi N; Ogura T; Yumikura S; Nagasawa M; Saito S; Ozawa Y
    Kokyu To Junkan; 1985 Jul; 33(7):897-902. PubMed ID: 4059680
    [No Abstract]   [Full Text] [Related]  

  • 39. What is 'reperfusion injury'?
    Ostadal P
    Eur Heart J; 2005 Jan; 26(1):99; author reply 99-100. PubMed ID: 15615806
    [No Abstract]   [Full Text] [Related]  

  • 40. About EMIP-FR and reperfusion damage in AMI: a comment to the comment.
    Marzilli M; Mariani M
    Eur Heart J; 2001 Jun; 22(11):973-5; author reply 978. PubMed ID: 11428823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.